Sahni Sonu, Capozzi Barbara, Iftikhar Asma, Sgouras Vasiliki, Ojrzanowski Marcin, Talwar Arunabh
North Shore - Long Island Jewish Health System, Department of Pulmonary, Critical Care and Sleep Medicine, New Hyde Park, NY, USA.
Touro College of Osteopathic Medicine, Department of Primary Care, New York, NY, USA.
J Exerc Rehabil. 2015 Apr 30;11(2):74-9. doi: 10.12965/jer.150190. eCollection 2015 Apr.
Pulmonary arterial hypertension (PAH) is a rare and devastating disease characterized by progressive increases in pulmonary arterial pressure and pulmonary vascular resistance which eventually leads to right ventricular failure and death. Early thought process was that exercise and increased physical activity may be detrimental to PAH patients however many small cohort trials have proven otherwise. In addition to the many pharmaceutical options, exercise and pulmonary rehabilitation have also been shown to increase exercise capacity as well as various aspects of psychosomatic health. As pulmonary and exercise rehabilitation become more widely used as an adjuvant therapy patient outcomes improve and physicians should consider this in the therapeutic algorithm along with pharmacotherapy.
肺动脉高压(PAH)是一种罕见且严重的疾病,其特征是肺动脉压力和肺血管阻力逐渐增加,最终导致右心室衰竭和死亡。早期的观点认为运动和增加体力活动可能对PAH患者有害,然而许多小型队列试验证明并非如此。除了多种药物选择外,运动和肺康复也已被证明可以提高运动能力以及身心健康的各个方面。随着肺康复和运动康复作为辅助治疗方法的应用越来越广泛,患者的预后得到改善,医生在治疗方案中应将其与药物治疗一起考虑。